Functional significance of the thyrotropin receptor germline polymorphism D727E

Biochemical and Biophysical Research Communications

Volumn 301, Issue 4, 2003, Pages 1051-1056

  Sykiotis, Gerasimos P ^a,b   Neumann, Susanne ^c   Georgopoulos, Neoklis A ^b   Sgourou, Argyro ^b   Papachatzopoulou, Adamantia ^a   Markou, Kostas B ^b   Kyriazopoulou, Venetsana ^b   Paschke, Ralf ^c   Vagenakis, Apostolos G ^b   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Activating mutation; G protein activation; Germline polymorphism; Thyrotropin receptor

Indexed keywords

ALANINE; ARGININE; CYCLIC AMP; THYROTROPIN RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CODON; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GERM LINE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; THYROID ADENOMA; WILD TYPE;

EID: 0037459101     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00071-8     Document Type: Article

References (22)

1. Dumont J.E., Lamy F., Roger P., Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72:1992;667-697.
2. Nagayama Y., Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol. Endocrinol. 6:1992;145-156.
3. Parma J., Duprez L., van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:1993;649-651.
4. Dumont J.E., Jauniaux J.C., Roger P.P. The cyclic AMP-mediated regulation of cell proliferation. Trends Biochem. Sci. 14:1989;67-71.
5. Lyons J., Landis C.A., Harsh G., Vallar L., Grunewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H.R., McCormick F. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
6. Nebel T., Trultzsch B., Paschke R. The TSH receptor mutation database. J. Clin. Endocrinol. Metab. 84:1999;2263.
7. Vassart G. New pathophysiological mechanisms for hyperthyroidism. Horm. Res. 48(S4):1997;47-50.
8. Gabriel E.M., Bergert E.R., Grant C.S., van Heerden J.A., Thompson G.B., Morris J.C. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J. Clin. Endocrinol. Metab. 84:1999;3328-3335.
9. de Roux N., Misrahi M., Chatelain N., Gross B., Milgrom E. Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Mol. Cell. Endocrinol. 117:1996;253-256.
10. Muhlberg T., Herrmann K., Joba W., Kirchberger M., Heberling H.J., Heufelder A.E. Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. J. Clin. Endocrinol. Metab. 85:2000;2640-2643.
11. Nogueira C.R., Kopp P., Arseven O.K., Santos C.L., Jameson J.L., Medeiros-Neto G. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid. 11:1999;1063-1068.
12. Tonacchera M., Pinchera A. Thyrotropin receptor polymorphisms and thyroid diseases. J. Clin. Endocrinol. Metab. 85:2000;2637-2639.
13. C. Hedinger, E.D. Williams, L.H. Sobin, Histological typing of thyroid tumors, in: WHO. International Histological Classification of Tumors, Springer, Berlin, 1998, pp. 5-6.
14. Duprez L., Parma J., Costagliola S., Hermans J., van Sande J., Dumont J.E., Vassart G. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett. 409:1997;469-474.
15. Wonerow P., Chey S., Fuhrer D., Holzapfel H.P., Paschke R. Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clin. Endocrinol. (Oxf). 53:2000;461-468.
16. Arseven O.K., Wilkes W.P., Jameson J.L., Kopp P. Substitutions of tyrosine601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11. Thyroid. 10:2000;3-10.
17. Szkudlinski M.W., Fremont V., Ronin C., Weintraub B.D. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol. Rev. 82:2002;473-502.
18. Wonerow P., Neumann S., Gudermann T., Paschke R. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. J. Mol. Med. 79:2001;707-721.
19. Biebermann H., Schoneberg T., Schulz A., Krause G., Gruters A., Schultz G., Gudermann T. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J. 12:1998;1461-1471.
20. Govaerts C., Lefort A., Costagliola S., Wodak S.J., Ballesteros J.A., van Sande J., Pardo L., Vassart G. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J. Biol. Chem. 276:2001;22991-22999.
21. Kosugi S., Mori T. The amino-terminal half of the cytoplasmic tail of the thyrotropin receptor is essential for full activities of receptor function. Biochem. Biophys. Res. Commun. 200:1994;401-407.
22. Wonerow P., Schonenberg T., Schultz G., Gudermann T., Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. J. Biol. Chem. 273:1998;7900-7905.